Across TCGA pan-cancer cohorts, CETN4P RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated CETN4P data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher CETN4P RNA is associated with better overall survival. In most high-consensus cancer types, elevated CETN4P expression acts as an unfavorable survival marker, although some lineages such as UCS and ACC show a favorable association.

UCS, KICH, and LUSC are the cancer types where CETN4P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	OS	Quartile	III,IV	0.708	0.277	.002	72	view →
KICH	DFS	Tertile	II,III,IV	0.440	1.000	<.001	68	view →
LUSC	DFS	Median	II,III,IV	0.650	0.784	.001	57	view →
HNSC	OS	Median	III,IV	0.216	0.418	.003	40	view →
MESO	DFS	Median	All	0.214	0.629	.002	21	view →
ACC	DFS	Median	IV	0.472	0.089	.012	19	view →
PAAD	DFS	Quartile	All	0.446	0.233	.023	19	view →
KIRP	OS	Quartile	All	0.880	0.538	.014	16	view →
OV	OS	Quartile	III,IV	0.622	0.756	.004	14	view →
COAD	DFS	Tertile	IV	0.288	0.580	.004	13	view →
LAML	DFS	Tertile	All	0.362	0.655	.007	12	view →
KIRC	DFS	Median	IV	0.650	0.263	.005	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

Exploration

Same gene, other analysis: CETN4P tumor-vs-normal RNA expression · all CETN4P data types